Why have you restricted Ivermectin?

Annie Weston made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Annie Weston

Dear Pharmaceutical Management Agency,

I had a phone consultation at 3.57pm Vodafone time on Thu 26 Aug 2021 with my General Practitioner.

I asked him to please prescribe me Ivermectin as a prophylactic for Covid-19.

He said he could not prescribe me Ivermectin because it was restricted by Pharmac.

Please can you provide me with the scientific evidence and any corresponding back-up data you used in your decision to restrict this drug for the prevention and/or treatment of Covid-19 in New Zealand.

Please see below link for the FLCCC Alliance's review.

https://covid19criticalcare.com/guide-fo...

I reserve the right to use your response in a court of law.

Yours faithfully,

Annie Weston

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2021 22 025 2021 09 01 OIA response letter Ivermectin for the prevention and or treatment of Covid 19 in New Zealand.pdf
112K Download View as HTML


Mōrena Annie

Please find a response to your request about ivermectin attached with this email.

Ngā mihi

Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz

-----Original Message-----
From: Annie Weston <[FOI #16515 email]>
Sent: Thursday, 26 August 2021 8:26 pm
To: Web Enquiry <[email address]>
Subject: Official Information request - Why have you restricted Ivermectin?

Dear Pharmaceutical Management Agency,

I had a phone consultation at 3.57pm Vodafone time on Thu 26 Aug 2021 with my General Practitioner.

I asked him to please prescribe me Ivermectin as a prophylactic for Covid-19.

He said he could not prescribe me Ivermectin because it was restricted by Pharmac.

Please can you provide me with the scientific evidence and any corresponding back-up data you used in your decision to restrict this drug for the prevention and/or treatment of Covid-19 in New Zealand.

Please see below link for the FLCCC Alliance's review.

https://covid19criticalcare.com/guide-fo...

I reserve the right to use your response in a court of law.

Yours faithfully,

Annie Weston

-------------------------------------------------------------------

This is an Official Information request made via the FYI website.

Please use this email address for all replies to this request:
[FOI #16515 email]

Is [PHARMAC request email] the wrong address for Official Information requests to Pharmaceutical Management Agency? If so, please contact us using this form:
https://fyi.org.nz/change_request/new?bo...

Disclaimer: This message and any reply that you make will be published on the internet. Our privacy and copyright policies:
https://fyi.org.nz/help/officers

If you find this service useful as an Official Information officer, please ask your web manager to link to us from your organisation's OIA or LGOIMA page.

-------------------------------------------------------------------

This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

From: Annie Weston

Dear Rachel,

Thank you for your quick reply.

However I did not ask why you are not funding Ivermectin.

I asked why you have restricted its use for the prevention and/or treatment of Covid-19 ie: my doctor is specifically not permitted to prescribe it off label for Covid-19.

Please refer to below link for the scientific rationale that justifies the use of Ivermectin in the prevention and treatment of Covid-19.

https://covid19criticalcare.com/ivermect...

Many thanks,

Annie Weston

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2021 22 025 2021 09 17 OIA response letter follow up regarding ivermectin for the prevention and or treatment of Covid 19 in New Zealand.pdf
113K Download View as HTML


Mōrena Annie

Please find attached a response to your further correspondence regarding ivermectin.

Ngā mihi

Melody Willis (she/her) | Government Services Advisor
___________________________________________________________________
Te Pātaka Whaioranga | Pharmac | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: +64 4 460 4990 |www.pharmac.govt.nz
This e-mail message and any accompanying attachments may contain confidential information. If you are not the intended recipient, please do not read, use, disseminate, distribute or copy this message or attachments. If you have received this message in error, please notify the sender immediately and delete this message.

hide quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: